Author

Nasimudeen R Jabir

King Abdulaziz University, Jaddah, Saudi Arabia - Cited by 2,599 - Inflammatory Disorders - Nanomedicine - Phytochemicals - Genomics - Computational chemistry

Biography

Nasimudeen R Jabir, Metabolomics & Enzymology Unit, Fundamental and Applied Biology Group, King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia.
Title
Cited by
Year
Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer’s disease
NR Jabir, FR Khan, S TabrezCNS neuroscience & therapeutics 24 (9), 753-762, 2018201
120
2018
Correlation of Toll‐like receptor 4, interleukin‐18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults
S Banu, NR Jabir, R Mohan, NC Manjunath, MA Kamal, KR Vinod Kumar, ...Journal of Periodontology 86 (3), 431-439, 2015201
87
2015
Neuroprotective role of steroidal sex hormones: an overview
AN Siddiqui, N Siddiqui, RA Khan, A Kalam, NR Jabir, MA Kamal, ...CNS neuroscience & therapeutics 22 (5), 342-350, 2016201
85
2016
An insight into the therapeutic potential of major coffee components
MT Islam, S Tabrez, NR Jabir, M Ali, MA Kamal, L da Silva Araujo, ...Current Drug Metabolism 19 (6), 544-556, 2018201
47
2018
An overview on the current status of cancer nanomedicines
NR Jabir, K Anwar, CK Firoz, M Oves, MA Kamal, S TabrezCurrent medical research and opinion 34 (5), 911-921, 2018201
45
2018
Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges
S Tabrez, NR Jabir, VM Adhami, MI Khan, M Moulay, MA Kamal, ...Nanomedicine 15 (11), 1147-1162, 2020202
40
2020
An insight on the association of glycation with hepatocellular carcinoma
NR Jabir, S Ahmad, S TabrezSeminars in cancer biology 49, 56-63, 2018201
40
2018
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers
CK Firoz, NR Jabir, MA Kamal, MN Alama, GA Damanhouri, W Khan, ...IUBMB life 67 (6), 453-459, 2015201
36
2015
A putative association of interleukin‐10 promoter polymorphisms with cardiovascular disease
S Tabrez, M Ali, NR Jabir, CK Firoz, GM Ashraf, S Hindawi, ...Iubmb Life 69 (7), 522-527, 2017201
33
2017
Assessment of genetic diversity in IL‐6 and RANTES promoters and their level in Saudi coronary artery disease patients
NR Jabir, CK Firoz, MA Kamal, GA Damanhouri, MN Alama, AS Alzahrani, ...Journal of Clinical Laboratory Analysis 31 (5), e22092, 2017201
33
2017
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
B Islam, NR Jabir, S TabrezJournal of drug targeting 27 (9), 932-942, 2019201
31
2019
Clinical and angiographic correlation of high‑sensitivity C‑reactive protein with acute ST elevation myocardial infarction
S Tanveer, S Banu, NR Jabir, MS Khan, GM Ashraf, NC Manjunath, ...Experimental and therapeutic medicine 12 (6), 4089-4098, 2016201
29
2016
Assessment of chemotherapy on various biochemical markers in breast cancer patients
MFCJ Paz, AL Gomes, MT Islam, S Tabrez, NR Jabir, MZ Alam, ...Journal of cellular biochemistry 119 (3), 2923-29, 2018201
28
2018
An overview on global trends in nanotechnological approaches for Alzheimer therapy
G Md Ashraf, S Tabrez, N R Jabir, CK Firoz, S Ahmad, I Hassan, A Alexiou, ...Current drug metabolism 16 (8), 719-727, 2015201
28
2015
In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease
NR Jabir, S Shakil, S Tabrez, MS Khan, MT Rehman, BA AhmedJournal of Biomolecular Structure and Dynamics 39 (14), 5083-5092, 2021202
27
2021
The use of azoles containing natural products in cancer prevention and treatment: An overview
NR Jabir, CK Firoz, A Bhushan, S Tabrez, MA KamalAnti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018201
26
2018
Cardiovascular disease management through restrained inflammatory responses
N R Jabir, S TabrezCurrent Pharmaceutical Design 22 (7), 940-946, 2016201
23
2016
A synopsis of nano-technological approaches toward anti-epilepsy therapy: present and future research implications
N R Jabir, S Tabrez, CK Firoz, S Kashif Zaidi, S S Baeesa, S Hua Gan, ...Current drug metabolism 16 (5), 336-345, 2015201
23
2015
Biosynthesis of copper oxide nanoparticles and its therapeutic efficacy against colon cancer
S Tabrez, AU Khan, AA Mirza, M Suhail, NR Jabir, TA Zughaibi, M AlamNanotechnology Reviews 11 (1), 13-1331, 202
22
2022
Reduction in CD16/CD56 and CD16/CD3/CD56 natural killer cells in coronary artery disease
NR Jabir, CK Firoz, F Ahmed, MA Kamal, S Hindawi, GA Damanhouri, ...Immunological Investigations 46 (5), 526-535, 2017201
22
2017

Referred From: https://scholar.google.com/citations?user=fTOEG-8AAAAJ&hl=en&oi=ao

Cited by
Citations 2599
h-index 27
i10-index 51
Recommended Journals
Open Access Journals